Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Sabby Capital and Alliqua Biomedical, Inc. (ALQA)

Hal Mintz’s Sabby Capital disclosed a 1.5 million share position in Alliqua Biomedical Inc. (ALQA) last week. Sabby Capital held 665 thousand shares of ALQA at the end of 2015. Alliqua Biomedical is a tiny stock, yet several hedge funds have large positions in the stock. Perceptive Advisors, which returned 50% in 2015, owned 1.92 million shares at the end of 2015. James Flynn’s Deerfield Management also had a similar position, holding 1.88 million shares.